2020
DOI: 10.1007/s00428-020-02906-5
|View full text |Cite
|
Sign up to set email alerts
|

Molecular and clinicopathological features of appendiceal mucinous neoplasms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 33 publications
0
18
0
Order By: Relevance
“…Some studies have shown that the pathway differs in appendiceal lesions in that the KRAS mutation is present but the BRAF mutation is less commonly found ( 7 ). Interestingly, several studies have revealed that the LAMNs are more likely to be associated with high-frequency mutation of KRAS ( 13 15 ). In the present study, we found four incidental LAMNs with a background of serrated lesions.…”
Section: Discussionmentioning
confidence: 99%
“…Some studies have shown that the pathway differs in appendiceal lesions in that the KRAS mutation is present but the BRAF mutation is less commonly found ( 7 ). Interestingly, several studies have revealed that the LAMNs are more likely to be associated with high-frequency mutation of KRAS ( 13 15 ). In the present study, we found four incidental LAMNs with a background of serrated lesions.…”
Section: Discussionmentioning
confidence: 99%
“…According to cytology, AMN is classified into low-grade and high-grade by the WHO Classification of Tumors of the Digestive System (2019), which is defined as a tumor with appendiceal mucinous epithelial hyperplasia, accompanied by extracellular mucus and “pushing” tumor border ( 6 ). Some studies demonstrated that KRAS and GNAS gene mutations occurred in LAMN ( 22 , 23 ), and patients with high-grade AMN manifested mutations of KRAS and GNAS, along with TP53, as well as ATM ( 24 ). The pathogenesis needs to be further studied.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies (Valasek and Pai 2018;Nummela et al 2015) have identified abnormal TP53 expression in a significant fraction (30%) of high-grade mucinous adenocarcinoma. Considering that only 7% of low-grade tumours show this characteristic, TP53 status appears to be the only marker associated with the acquisition of an aggressive phenotype in tumours with PMP.…”
Section: Discussionmentioning
confidence: 99%
“…KRAS mutations (preferentially observed in exon 2) seem to have a pivotal role in the development of appendiceal mucinous neoplasms (Kabbani et al 2002 ; Borazanci et al 2017 ). KRAS is mutated in 41–100% of appendiceal mucinous adenomas (Szych et al 1999 ; Zauber et al 2011 ; Yantiss et al 2007 ; Tsai et al 2019 ; Liao et al 2020 ; Yanai et al 2020 ). Pai et al ( 2014 ) analysed a series of 132 appendiceal lesions, revealing that serrated lesions of the appendix often harbour KRAS mutations and only infrequently display BRAF mutations.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation